ライフサイエンスコーパス: currently licensed

1 a stand-alone vaccine or in combination with currently licensed adjuvants for lymphoma immunotherapy.

2 Many currently licensed and commercially available human vacc

3 ered survey to 800 physicians and 800 nurses currently licensed and practicing in Minnesota.

4 c than TFT, which is the only effective drug currently licensed and routinely used for topical treatm

5 k-benefit balance seems to be acceptable for currently licensed anti-B cell agents, additional studie

6 Compared to currently licensed assays, an ELISA incorporating a comb

7 cine to protect infants too young to receive currently licensed attenuated measles vaccines.

8 butable to carcinogenic HPV16/18 targeted by currently licensed bivalent and quadrivalent HPV vaccine

9 However, the currently licensed Dryvax vaccine, despite its documente

10 To provide a review of currently licensed enteric vaccines and their efficacy b

11 e, immunogenic, and highly protective and is currently licensed for human use in Argentina.

12 loride, a potassium sparing diuretic that is currently licensed for hypertension and congestive cardi

13 n adjuvants such as alum and MF59, which are currently licensed for influenza or other vaccines.

14 3-carboxamide) is a nontoxic antiviral agent currently licensed for the treatment of severe RSV lower

15 Docetaxel is currently licensed for use in a variety of malignancies,

16 at the combination of two adjuvants that are currently licensed for use in humans can be used to prim

17 However, currently licensed human vaccines are subtype-specific a

18 The vast majority of currently licensed human vaccines work on the basis of l

19 The currently licensed imaging modalities are limited by lac

20 tarix, a monovalent human rotavirus, are now currently licensed in many countries.

21 same methods that have been used to generate currently licensed inactivated H5N1 vaccines, we were ab

22 as promising single-dose vaccines to replace currently licensed inactivated RV-based vaccines.

23 This review focuses on how currently licensed influenza vaccines are generated in t

24 unological bases for the efficacies of the 2 currently licensed influenza vaccines, live attenuated i

25 ve immune response and the main component of currently licensed influenza vaccines.

26 Currently licensed influenza virus vaccines rely on the

27 Currently licensed nonstandardized allergen extracts wer

28 The currently licensed polysaccharide vaccine provides 60 to

29 oligosaccharides may offer no advantage over currently licensed preparations containing unconjugated

30 risk of intussusception (IS) associated with currently licensed rotavirus vaccines (RV1 [Rotarix; GSK

31 ressing a non-vaccine type (according to the currently licensed seven-valent conjugate vaccine).

32 The exploratory analysis of currently licensed sofosbuvir treatment regimens found t

33 species appear to be less susceptible to the currently licensed systemic antifungal agents, with the

34 this end, we evaluated the performance of 12 currently licensed tests and 1 in-house HIV test (6 EIA,

35 e that alternative algorithm strategies with currently licensed tests compare favorably with the conv

36 ted States, 2 types of influenza vaccine are currently licensed: trivalent inactivated influenza vacc

37 ar short-term immunological responses to the currently licensed two-dose regimen.

38 vailable, has few toxic side effects, and is currently licensed under the name Elmiron for the treatm

39 However, the currently licensed vaccine is poorly immunogenic in infa

40 ses can be constructed within the context of currently licensed vaccine platforms.

41 ains a serious bioterrorism concern, and the currently licensed vaccine remains an incomplete solutio

42 needed to overcome the disadvantages of the currently licensed vaccine strains that restrict their u

43 Currently licensed vaccine strains used in animals are u

44 rotection for many human vaccines, including currently licensed vaccines against flaviviruses.

45 The three currently licensed vaccines contain virus-like particles

46 Two currently licensed vaccines have been successful in redu

47 Although most currently licensed vaccines provide protection via the i

48 thogenesis and disease progression, evaluate currently licensed vaccines, and develop improved vaccin

49 eligibility, availability, and efficacies of currently licensed vaccines, and review the results of r

50 immunosenescence and the immune response to currently licensed vaccines.

51 All currently licensed yellow fever (YF) vaccines are propag